9 Stocks George Soros Is Buying for 2015: Yahoo!, American Airlines and More



NEW YORK (Stockpickr) -- At Stockpickr, we track the top holdings of a variety of high-profile investors, such as Warren Buffett and Carl Icahn.

One of our most popular professional portfolios is that of George Soros' Soros Fund Management. Keeping in mind that Soros Fund Management conducts hundreds of transactions every quarter -- in the most recently reported quarter, for example, the firm increased its stake or purchased new positions in close to 200 stocks -- we thought we'd single out some of its recent top buys.

What follows is a closer look at nine of the 30 holdings that Stockpickr tracks in its George Soros portfolio. These stocks all saw position increases in the most recently reported quarter ended Sept. 30.

9. Dow Chemical

Dow Chemical (DOW) comprises 1.1% of Soros' portfolio as of the most recently reported quarter. The 2.9 million-share position is an increase of 2.1 million shares, or 253.44%, over the previous quarter.

TheStreet Ratings team rates Dow Chemical as a buy with a ratings score of A-. TheStreet Ratings team has this to say about its recommendation:

"We rate Dow Chemical (DOW) a buy. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins."

Highlights from the analysis by TheStreet Ratings Team goes as follows:

  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Chemicals industry. The net income increased by 38.0% when compared to the same quarter one year prior, rising from $679.00 million to $937.00 million.
  • Despite its growing revenue, the company underperformed as compared with the industry average of 6.8%. Since the same quarter one year prior, revenues slightly increased by 4.9%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • The debt-to-equity ratio is somewhat low, currently at 0.77, and is less than that of the industry average, implying that there has been a relatively successful effort in the management of debt levels. Along with the favorable debt-to-equity ratio, the company maintains an adequate quick ratio of 1.29, which illustrates the ability to avoid short-term cash problems.
  • Net operating cash flow has increased to $1,775.00 million or 26.60% when compared to the same quarter last year. The firm also exceeded the industry average cash flow growth rate of -13.80%.

You can view the full analysis from the report here: DOW Ratings Report

If you liked this article you might like

Why Bayer's $66 Billion Takeover of Monsanto Probably Won't Happen Until 2018

Cramer: The Market Is Back to the Late '80s, Early '90s

DowDupont Closes Higher in First Day of Trading, Company Still Faces Challenges

FMC Stock's Impressive Rally Has Another 20% to Gain: Jim Cramer

Jim Cramer on Why FMC Was Upgraded by Bank of America